
Ingredion revenue inches higher to $1.85 billion
- Ingredion reported second-quarter net sales of $1.85 billion, up 1% from one year earlier.
- Ingredion shares were up 0.1% at $100.50 in premarket trading.
- The company reaffirmed adjusted EPS guidance of $10.30–$10.90 and advanced its Tate & Lyle acquisition.
Ingredion Incorporated (NYSE:INGR) reported second-quarter net sales of $1.85 billion, up 1%, while adjusted operating income fell 5% to $258 million.
Reported operating income declined 31% to $188 million, while adjusted diluted EPS slipped to $2.82 from $2.87 one year earlier.
U.S./CAN operating income fell 33% to $58 million after Argo production issues, while Texture & Healthful Solutions income rose 5% to $117 million.
Following the announcement, Ingredion's share price was up 0.1% at $100.50, as the company reaffirmed adjusted EPS guidance of $10.30–$10.90.
Ingredion sold a 51% stake in its Pakistan business for $165 million and retained a 20% ownership interest.
Meanwhile, Tate & Lyle shareholders accepted Ingredion’s 595 pence cash offer, with completion expected in the second half of 2027 subject to approvals.


